Correlation Between Akums Drugs and Max Healthcare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akums Drugs and Max Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akums Drugs and Max Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akums Drugs and and Max Healthcare Institute, you can compare the effects of market volatilities on Akums Drugs and Max Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akums Drugs with a short position of Max Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akums Drugs and Max Healthcare.

Diversification Opportunities for Akums Drugs and Max Healthcare

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Akums and Max is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Akums Drugs and and Max Healthcare Institute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Max Healthcare Institute and Akums Drugs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akums Drugs and are associated (or correlated) with Max Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Max Healthcare Institute has no effect on the direction of Akums Drugs i.e., Akums Drugs and Max Healthcare go up and down completely randomly.

Pair Corralation between Akums Drugs and Max Healthcare

Assuming the 90 days trading horizon Akums Drugs and is expected to under-perform the Max Healthcare. In addition to that, Akums Drugs is 2.18 times more volatile than Max Healthcare Institute. It trades about -0.16 of its total potential returns per unit of risk. Max Healthcare Institute is currently generating about 0.26 per unit of volatility. If you would invest  102,500  in Max Healthcare Institute on September 12, 2024 and sell it today you would earn a total of  10,720  from holding Max Healthcare Institute or generate 10.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Akums Drugs and  vs.  Max Healthcare Institute

 Performance 
       Timeline  
Akums Drugs 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akums Drugs and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Max Healthcare Institute 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Max Healthcare Institute are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile essential indicators, Max Healthcare disclosed solid returns over the last few months and may actually be approaching a breakup point.

Akums Drugs and Max Healthcare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akums Drugs and Max Healthcare

The main advantage of trading using opposite Akums Drugs and Max Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akums Drugs position performs unexpectedly, Max Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Max Healthcare will offset losses from the drop in Max Healthcare's long position.
The idea behind Akums Drugs and and Max Healthcare Institute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
CEOs Directory
Screen CEOs from public companies around the world
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules